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Abstract
Background: There is limited evidence on the efficacy and social utility of cognitive training. To address this, we
have designed a randomized controlled trial to assess the effectiveness of memory training workshops for healthy
older people in terms of their short- and long-term impact on cognitive function, health-related quality of life, and
functionality.
Methods/design: A randomized controlled trial will be performed in health care centers in Barcelona (Spain)
through comparison of a group of individuals participating in memory training workshops (experimental group)
with another group with similar characteristics not participating in the workshops (control group). The intervention
will consist of twelve 90-minute group sessions imparted once a week by a psychologist specialized in memory
training. The groups will each comprise approximately 15 people, for a total number of 230 patients involved in the
study. Each session has its own objectives, materials and activities. The content of the intervention is based on
memory training from different perspectives, including cognitive and emotional aspects and social and individual
skills. Data will be collected at baseline, at 3–4 months and at 6 months. To assess the efficacy of the intervention
on cognitive function, health-related quality of life and functionality, a statistical analysis will be performed by fitting
a repeated-measures mixed effects model for each main outcome: Self-perceived memory, measured by a Subjective
Self-reported Memory Score (from 0 to 10) and by the Memory Failures in Everyday life questionnaire (MFE); Everyday
memory, measured using the Rivermead Behavioural Memory Test-3 (RBMT-3) and Executive control abilities, measured
in terms of visual-perceptual ability, working memory and task-switching ability with the Trail Making Test (TMT) and
with the digit span scale of the Wechsler Adult Intelligence Scale III (WAIS III).
Discussion: The results of this study will be highly useful for social and public health policies related to older people.
Given the continuous increase in the prevalence of older people, a large number of interventions targeting memory
loss are funded by public resources. To ensure transparency and effective prioritization, research such as the present
study is needed to provide evidence of the effectiveness and usefulness of these interventions.
Trial registration: Number: NCT02431182.
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Background
Social changes in the twentieth century have been charac-
terized by worldwide population aging, especially in devel-
oped countries. This has led to major changes in disease
distribution, with an increase in the prevalence of chronic
and degenerative diseases, including cognitive impairment
and dementia. Between 2000 and 2050, the proportion of
the global population older than 60 years will double from
approximately 11 % (605 million people) to 22 % (2 billion
people) [1]. In Spain, the estimated proportion of people
older than 64 years in 2050 is approximately 30 % of the
population [2]. In 2012, an estimated 8.4 million people
aged 60 years and older had dementia in European Union
member states, accounting for 7 % of the population in
that group. Spain had one of the highest prevalence rates
of dementia, which affects more than 7.5 % of the popula-
tion aged 60 years and older [3].
Consequently, there is increased interest in new
pharmacologic treatments for dementia as well as in
non-pharmacological preventive interventions. These
non-pharmacological interventions are mainly based on
cognitive training to optimize the performance of exist-
ing functions and to decrease the risk of cognitive im-
pairment. The benefits of teaching rehabilitative and
compensatory strategies in older persons who already
have memory complaints have been shown in multiple
studies [4]. However, the evidence on the effects of cog-
nitive training on cognition in healthy elderly persons
is less conclusive [5]. A systematic review of random-
ized controlled trials in healthy older persons con-
cluded that training improved immediate performance
on related tasks, but that there was no evidence for any
generalizability of training [5]. Among the studies included
in that review, a notable publication was the ACTIVE trial,
which included 2800 healthy elders. In that trial, partici-
pants demonstrated significant changes in each of the three
cognitive abilities for which they had received training:
memory, inductive reasoning, and speed of processing.
The authors estimated that the magnitude of the observed
effect was equivalent to avoiding the impairment that
would take place in the natural course of life of healthy
people in a period between 7 and 14 years [6]. Overall,
some of the characteristics associated with the success of
the interventions described were the group structure, the
duration (at least 8–10 sessions) and the intensity (60–90
minutes each session). In terms of content, there was no
clear pattern of methods or strategies, although most of
the interventions that were successful used memory train-
ing techniques, especially for episodic memory [7, 8].
Given the limited evidence available on the efficacy and
social utility of cognitive training, we have designed a ran-
domized controlled trial to assess the effectiveness of cog-
nitive training through memory training workshops offered
to healthy older persons in terms of their immediate and
delayed impact on cognitive function, health-related quality
of life and functionality.
The paper partially meets the requirements for the PhD
program of Anna Pérez Giménez at the Pompeu Fabra
University (Barcelona, Spain).
Hypothesis
The group memory training intervention proposed in this
protocol will significantly improve cognition (memory, at-
tention and executive control abilities) and health-related
quality of life (HRQoL) in the experimental group (EG)
compared with the control group (CG).
Objectives
Principal objective
To assess the efficacy of a memory training workshop in
improving self-perceived memory, everyday memory, and
executive control abilities.
Secondary objective
To assess the effect of the memory training workshop
on HRQoL and on late-life function and disability.
Methods
Study design
This is a randomized controlled trial, comparing a group
of individuals taking part in the memory training work-
shops (EG) with another group with similar characteristics
not attending the workshops (CG). Data will be collected
at baseline and at 3 and 6 months.
Study setting and participants
The study will be conducted in health care centers in
Barcelona (Spain). Included participants comprise healthy
older people registered in any of the four health care cen-
ters included in the study and meeting the inclusion cri-
teria. The inclusion criteria are: a) men and women aged
between 65 and 80 years (inclusive) who consent to par-
ticipate in the study; b) not presenting with diagnoses of
dementia or cognitive impairment measured through the
Mini-Mental State Examination (MMSE >24) [9, 10] and
c), absence of depression measured using the Geriatric
Depression Scale (GDS 5 ≤ 2) [11]. The exclusion criteria
are: a) having participated in a memory training program
within the last 3 years; b) having a severe sensorial disabil-
ity and c) being unable to read or write. Each participant
has the right to withdraw from the study at any time. In
addition, a participant may be withdrawn from the study if
deemed necessary by the researchers based on any of the
following withdrawal criteria: a) adverse experience; b) sig-
nificant non-adherence to the intervention (missing more
than 50 % of the sessions); c) loss-to-follow-up; d) clinical
conditions not allowing the participant to continue in the
study (such as illness and accident); and e) death.
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Description of the study (Figure 1):
Figure 1 outlines the participant flowchart of the study
procedure:
1. Enrollment: Recruitment will be conducted in the
four participating health care centers through
printed materials (leaflets and posters) in the health
care centers and close community sites (library,
pharmacy, market or older persons’ meeting center).
Interested individuals will be required to contact
their corresponding health care center, where they
will first be screened for age (older than 65 years
and younger than 81 years) and previous memory
training (not having received memory training
during the 3 previous years). Those who meet both
criteria will be given an appointment to attend an
inclusion interview with a study-specific trained
physician or nurse at the health care center. Informed
consent follows the requirements of the l’Institut
d’Investigació en Atenció Primària Jordi Gol (IDIAP
Jordi Gol) Clinical Research Ethics Committee.
Written consent to participate will be obtained
from each person at the beginning of the screening
interview. Participants will be selected through the
screening interview, which will be used to gather
socio-demographic data and enquire about the
participant’s medical history and active clinical
diagnoses and medications. The GDS-5 and the
MMSE will be administered.
2. Allocation: After the screening interview, and if the
participant is eligible and willing, he or she will be
randomly assigned to the EG or to the CG using a
closed, opaque envelope with the group information
inside. The total time required for screening will be
around 30 minutes.
3. Baseline and follow-up assessments: Three
assessments will be conducted during the study
period: at baseline after randomization, between 3 and
4 months post-intervention (short-term post-test),
and at 6 months post-intervention (long-term
Fig. 1 Flowchart of enrollment, allocation and follow up
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post-test). All three assessments will collect information
on the variables detailed in Table 1 and will be
conducted by a trained psychologist through
in-person interviews in the health care center.
Time requirements will be approximately 75 minutes
for the baseline assessment and approximately
90 minutes for the follow-up assessments.
Standardization of data collection procedures will
be ensured through a variety of training and
quality-control procedures adhering to CONSORT
guidelines for transparent reporting [12]. Data
collectors will be blind to the treatment group
assignment. All data collectors will participate in
an intensive 2-day training workshop that will
include information on the study design, recruitment
issues, and general research interviewing principles;
detailed instruction on the administration of each test
or measurement procedure; demonstrations of each
test/measurement; and practice sessions with other
data collectors. Furthermore, the data collectors will
use a user-friendly answer sheet specially designed for
the study. All completed sheets will be reviewed by
the fieldwork coordinator who, if there are missing
data or possible mistakes, will contact the data
collectors to resolve any queries.
Description of the intervention
Once the baseline assessment has been conducted, indi-
viduals in the EG will start the multifactorial intervention.
The memory training workshop is designed to stop or
delay age-related memory losses and promote personal
autonomy, thus enhancing mental and physical wellbeing.
Specifically, these workshops aim to broaden knowledge
on memory function, improve memory processes, and in-
crease self-esteem and quality of life by providing some
strategies (i.e., strategies for collecting and coding infor-
mation) and relational space. The intervention will consist
of twelve 90-minute group sessions provided once a week
by a psychologist specialized in memory training. The
groups will be composed of around 15 people. Each
session will have its own objectives, materials, and ac-
tivities (Table 2). The content of the intervention is
based on memory training from different perspectives
such as cognitive and emotional aspects and social and
individual skills.
Outcome measures
Screening variables: Depressive symptoms will be mea-
sured using the GDS [13], which has been adapted and
validated for the Spanish geriatric population [14]. The
shortened, GDS-5 will be used to screen potential partic-
ipants [15]. The GDS-15 version will be used for the fol-
low-up assessments [16]. Cognitive function will be
evaluated using the 11-item MMSE, which will be used to
screen probable cognitively-impaired individuals (MMSE
values below 24 points) [17]. Sociodemographic information
will be collected on age, gender, marital status, living ar-
rangements, education level, last occupation, and residen-
tial neighborhood. Individual socioeconomic status will be
obtained through the last occupation of the individual ac-
cording to the last classification of the Spanish Society of
Epidemiology [18]. The residential neighborhood will allow
an ecological socioeconomic score to be obtained, based
on indicators such as graduate rates, unemployment rates,
vehicles, second-hand home prices, and the Disposable
Household Income Index [19].
Main outcomes
Self-perceived memory will be measured using a subject-
ive self-reported memory score (from 0 to 10), as well as
with the Memory Failures in Everyday life questionnaire
(MFE). This questionnaire consists of 28 items and uses
a Likert-type scale referring to perception of everyday
memory problems [20–22].
Table 1 Tests and other data for the evaluation of the memory training workshop
ASSESSMENTS
Screening Baseline Immediate Post-test Delayed post-test
Medical History X
Socio-demographic data X
GDS-5 X X X
MMSE X X X
RBMT-3 X X X
SF-36 X X X
Subjective Self-reported Memory Score X X X
MEF X X X
WAIS X X X
TMT X X X
SF-LLFDI X X X
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Everyday memory will be measured using the River-
mead Behavioural Memory Test-3 (RBMT-3) [23]. This
cognitive test evaluates different types of memory, such as
associative memory, prospective memory, visual memory,
topographical memory, and verbal memory. The test pro-
vides a General Memory Index and different subtest scales.
Executive control abilities will be measured in terms of
visual-perceptual ability, working memory and task-
switching ability with the Trail Making Test (TMT)
[24]. This neuropsychological test is divided into two
parts and the score on each part represents the amount
of time required to complete the task [25]. Working
memory will also be assessed using the digit span scale
of the Wechsler Adult Intelligence Scale III (WAIS III).
Secondary outcomes
Health-Related Quality of Life (HRQoL) will be assessed
using the Short Form-36 (SF-36) [26, 27], with a vali-
dated Spanish version [28, 29]. Of the 36 items, 35 make
up eight scales: physical functioning, role limitations due
to physical functioning, bodily pain, general health per-
ceptions, vitality, social functioning, role limitations due
to emotional problems, and mental health [26].
Functionality and disability will be measured with the
Spanish Version of the Short-Form Late-Life Function
and Disability Instrument (SFLLFDI) [30, 31]. The LLFDI
was developed as a comprehensive assessment of function
and disability for use in community-dwelling older adults.
It contains items that represent functional limitations (in-
ability to perform discreet physical tasks encountered in
daily routines) and disability (inability to take part in
major life tasks and social roles).
Intervention-related variables
Other variables related to the implementation of the inter-
vention will be collected, such as the number of sessions
the person has attended, the participants’ satisfaction with
the workshops, the usefulness of the program, and overall
impressions. The professionals conducting the workshops
will also evaluate individual and group progress.
Sample size calculation
The sample size was calculated to detect a difference in
everyday memory higher than 2 points (0.5 SD) on the
mean RBMT-3 score between the control and the inter-
vention group [32]. Accepting an alpha risk of 0.05 and
a beta risk of 0.1 in a bilateral contrast, and assuming a
mean score of 16.07 and an SD of 4.19 [33] on the
RBMT-3 in the Spanish population aged between 70 and
75 years, 75 individuals in each group will be needed. To
ensure this sample size and considering an estimated
rate of losses of 20 % in the EG and 40 % in the CG, the
final sample size needed is 195 individuals (90 in EG and
105 people in CG, respectively).
Statistical analysis
Baseline comparability between the study arms will be
assessed through bivariate analyses of the pre-test data
set group (dependent and independent variables) com-
paring the control and the experimental arms. The chi-
square test will be used to compare qualitative data, as
well as the Student t test or the Mann–Whitney test for
quantitative data, depending on the normality of the dis-
tribution. If differences are found in baseline characteris-
tics, we will consider adjusting for these variables in the
efficacy analysis.
A descriptive analysis will be conducted for results at
baseline, at the immediate follow-up and at the delayed
follow-up for the EG and CG. Categorical outcomes will be
described through raw frequencies or percentages, and con-
tinuous outcomes will be described through mean scores
and standard deviations. Effect measures for each outcome
at the immediate and delayed follow-ups will be computed
as the mean of the differences of the aggregated scores for
Table 2 Contents of the memory training workshop by session
SESSION CONTENT
1 Presentation of the workshop: Objectives and Methodology
2 Types of memory I: Explanation of the different types of memory and their role in normal life
3 Types of memory IIa: Strategies for gathering and codifying information.
4 Types of memory IIb: Strategies for selecting and storing information.
5 Types of memory III: Strategies for gathering, codifying, selecting, storing and retrieving information. Importance of the context and the
meaning of things. Semantic and episodic memory.
6 Types of memory IV: Strategies for gathering, codifying, selecting, storing and retrieving information. Individual differences.
7 Types of memory V: Strategies for retrieval according to individual profile. Improving self-esteem.
8 Types of memory VI: Strategies for recovering social skills.
9 Personal and social skills
10 New contexts and opportunities. Conceptual maps (physical and mental).
11 Evaluation of the workshop.
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the EG and CG. Effect measures will be presented with
their 95 % confidence intervals.
The main statistical analyses to assess the efficacy of the
intervention on self-perceived memory, everyday memory
and executive control abilities will be performed using a
repeated-measures mixed effects model for each main
outcome defined in the protocol [34]. In each model, the
independent variables will be the group (EG or CG), time
(baseline, immediate follow-up or delayed follow-up) and
any relevant characteristics that differ between the groups
at the baseline assessment (e.g., age or educational level).
An interaction term between time and group will be in-
cluded in the analyses. The models will be fitted with the
available data, ignoring missing data.
To determine whether the results have been influenced
by missing data, we will conduct sensitivity analyses by fit-
ting the models with completed datasets obtained by im-
puting the missing data [35]. In this analysis, missing
values for the immediate or delayed post-test assessments
will be imputed through the Last Observation Carried
Forward (LOCF) strategy. According to this strategy, miss-
ing values will receive the value obtained by the partici-
pant in the previous assessment. In addition, we will
perform sensitivity analyses restricted to those participants
attending at least 80 % of the sessions.
Ethics considerations
The participants will be informed both verbally and in
writing about the aims, methods, procedures and mea-
sures performed during this study. They will also be in-
formed about ethical issues such as confidentiality, their
right to ask any questions during the study and their right
to withdraw at any time. To ensure that all participants
have received information about this research project and
agreed to participate, all participants will be asked to sign
a written consent form. The research team is committed
to performing this study according to the Good Clinical
Practice Guidelines of the Declaration of Helsinki. This
protocol was approved by the Comitè Ètic d’Investigació
Clínica (CEIC) del IDIAP Jordi Gol.
Discussion
Quality control
Reliability and validity are considered to be the key cri-
teria for assessing the quality of quantitative studies. To
assure these qualities, the randomization list of this ran-
domized controlled trial will be computer-generated and
will remain concealed until the participants’ assignment to
each group. After the informed consent form has been
signed, a study entry number will be assigned to each par-
ticipant. This number will be on the outside of a closed,
opaque envelope, which will allocate the participant to ei-
ther the EG or the CG (single-blind allocation). Allocation
concealment will prevent the occurrence of selection bias
before the interventions are provided to the participants
[36]. In addition, the professionals who will carry out the
neurocognitive evaluations (pre-test, short-term post-test
and long-term post-test) and the memory training work-
shop professionals will not be aware of the group to which
each participant belongs.
The following procedures will also be used to guarantee
the quality of the information. The intervention will be car-
ried out by trained personnel who will follow the same
protocol and materials, thus guaranteeing the homogeneity
of the intervention. The same will occur with data collec-
tion, which will be conducted by specially trained profes-
sionals. Data will be collected through a specifically created
data-register sheet designed by Teleform® v.10.2 software.
This automated software reads scanned questionnaires and
performs a validation process of the data with previously
established parameters; once the data have been validated,
they are entered into a specifically created dataset.
Implications
The memory training workshop proposed in the present
study could be considered as paradigmatic of the memory
training interventions that are being conducted in Barce-
lona, even in Spain, as most of them follow the same pat-
tern. [8, 32, 37–39]. The results of this study will be very
useful for social and public health policies for older
people. The findings of this study should be considered
when decisions need to be made regarding investing pub-
lic resources in certain interventions.
Strengths and limitations
Our study has some important strengths; it is the first ran-
domized controlled trial aiming to demonstrate the effect-
iveness of memory training in healthy older people in
Spain. Additionally, we will apply a wide variety of vali-
dated tests, which will allow for assessment of the potential
impact of the intervention on several health-related out-
comes (memory, other executive control abilities, HRQoL,
life function and disability), as well as comparisons with
other studies.
A possible limitation is the length of follow up, less than
1 year, which may negatively affect our results because
some increases in memory problems may not be detected.
Another limitation of our study is that it does not include
a matched active control group. Therefore, we will not be
able to isolate the memory training effects from the poten-
tial confounding benefits of increased social contact.
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